IGF-1 LR3 0.1mg – Research Peptide

IGF-1 LR3 is supplied for laboratory and scientific research purposes.

Axis Therapies provides high purity research peptides manufactured in Australia, produced in controlled laboratory settings in Sydney with a focus on consistency and batch traceability.

IGF-1 LR3 is a synthetic peptide commonly studied in research relating to cellular growth pathways, signalling activity, and peptide interaction within controlled experimental models.

Each vial is produced to high purity standards, with batch referenced testing available where applicable.

Purity: ≥99%
Form: Lyophilised powder
Strength: 0.1mg per vial
Quantity: Sold per vial (multi packs available)
Manufactured in Australia (Sydney)
Testing: COA available for selected batches

This product is supplied strictly for laboratory research use only. Not for human or veterinary use.